Shannon James Samuel
SEC CIK 1485417 · EDGAR
BoughtSold
Most active insiders at XLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shannon James Samuel | Dir | $43.9K | — |
| 2 | Frankenfield Christopher James | CFO | — | $4,499 |
| 3 | Brennan Kevin M. | SVP, Fin AND ACCOUNTING | — | $1,169 |
| 4 | Luptakova Katarina | Chief MEDICAL Off | — | — |
| 5 | Russo Rene | Pres AND CEO, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | XLO | Xilio Therapeutics, Inc. | Shannon James Samuel | Dir | P - Purchase | $8.79 | +5,000 | 10.0K | +100% | +$43.9K | |
| 2026-03-03 | 2026-03-01 | MNKD | MANNKIND CORP | Shannon James Samuel | Dir | A - Grant | $3.27 | +12.0K | 64.6K | +23% | +$39.2K | |
| M | 2025-06-18 | 2025-06-16+ | XLO | Xilio Therapeutics, Inc. | Shannon James Samuel | Dir | P - Purchase | $0.69 | +70.0K | 70.0K | New | +$48.3K |
Purchase Sale Sale after option exercise All abbreviations